Secretary Robert F. Kennedy Jr. announced that the CDC will no longer recommend the COVID-19 booster vaccine for healthy children and pregnant people. The announcement comes despite previous CDC...
The FDA has announced that it will limit access to COVID-19 vaccines, making them only available to high-risk populations. The organization also announced that they will require manufacturers to further...
A 2-year follow-up of the COVAXID trial shows that repeated SARS-CoV-2 mRNA booster doses significantly improve antibody and T cell responses in immunocompromised patients, even among initial poor...
A 2-year follow-up of the COVAXID trial shows that repeated SARS-CoV-2 mRNA booster doses significantly improve antibody and T cell responses in immunocompromised patients, even among initial poor...
A prospective study assessed opioid-free anesthesia during total shoulder arthroplasty and found lower in-hospital opioid use and pain scores. This study will be presented on May 2, 2025, at the ASRA Annual...
A population-based cohort study found that receiving two or more doses of a COVID-19 vaccine was associated with a significantly lower risk of developing persistent post–COVID condition among individuals...
A population-based cohort study found that receiving two or more doses of a COVID-19 vaccine was associated with a significantly lower risk of developing persistent post–COVID condition among individuals...
A survey of outpatient physicians found that utilization management practices, including prior authorization and step therapy, are significant barriers to patient care and contribute to physician burnout.
...
A new study finds that electronic health record activity data are poor predictors of individual physician burnout but may help flag clinics where burnout risk is highest.
A new randomized clinical trial found that psilocybin therapy reduced symptoms of depression in frontline clinicians affected by the COVID-19 pandemic, with effects lasting up to 6 months.
